139 related articles for article (PubMed ID: 30145768)
1. Oligometastatic recurrence of an oesophageal adenocarcinoma at a chest drain site following radical treatment: palliative treatment or resection?
Wen D; Collantes E; Sgromo B
Clin J Gastroenterol; 2018 Dec; 11(6):470-475. PubMed ID: 30145768
[TBL] [Abstract][Full Text] [Related]
2. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of oesophagus metastasising to the subcutaneous soft tissue.
Tunio MA; Alasiri M; Riaz K
Arab J Gastroenterol; 2013 Sep; 14(3):133-4. PubMed ID: 24206744
[TBL] [Abstract][Full Text] [Related]
4. The prognostic and potentially predictive value of the Laurén classification in oesophageal adenocarcinoma.
van der Kaaij RT; Snaebjornsson P; Voncken FE; van Dieren JM; Jansen EP; Sikorska K; Cats A; van Sandick JW
Eur J Cancer; 2017 May; 76():27-35. PubMed ID: 28262585
[TBL] [Abstract][Full Text] [Related]
5. Oesophagectomy for tumours and dysplasia of the oesophagus and gastro-oesophageal junction.
Epari K; Cade R
ANZ J Surg; 2009 Apr; 79(4):251-7. PubMed ID: 19432710
[TBL] [Abstract][Full Text] [Related]
6. Complete resection of an isolated chest wall metastasis from esophageal carcinoma after transhiatal esophagectomy and gastric pull-up at one and a half-year follow-up.
Lindenmann J; Matzi V; Porubsky C; Maier A; Smolle-Juettner FM
J Thorac Oncol; 2007 Aug; 2(8):773-6. PubMed ID: 17762347
[TBL] [Abstract][Full Text] [Related]
7. Solitary recurrence at intercostal drain site in oesophageal adenocarcinoma.
Kajamohideen S; Venkitaraman B; Shivkumaran SM; Premkumar P
Indian J Thorac Cardiovasc Surg; 2020 May; 36(3):241-243. PubMed ID: 33061132
[TBL] [Abstract][Full Text] [Related]
8. Patterns of recurrence in early-stage oesophageal cancer after chemoradiotherapy and surgery compared with surgery alone.
Robb WB; Messager M; Dahan L; Mornex F; Maillard E; D'Journo XB; Triboulet JP; Bedenne L; Seitz JF; Mariette C; ; ; ; ;
Br J Surg; 2016 Jan; 103(1):117-25. PubMed ID: 26511668
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of neoadjuvant chemoradiation in cT3 oesophageal cancer - A propensity score matched analysis.
Hölscher AH; Bollschweiler E; Bogoevski D; Schmidt H; Semrau R; Izbicki JR
Eur J Cancer; 2014 Nov; 50(17):2950-7. PubMed ID: 25307749
[TBL] [Abstract][Full Text] [Related]
10. A phase 1 'window-of-opportunity' trial testing evofosfamide (TH-302), a tumour-selective hypoxia-activated cytotoxic prodrug, with preoperative chemoradiotherapy in oesophageal adenocarcinoma patients.
Larue RT; Van De Voorde L; Berbée M; van Elmpt WJ; Dubois LJ; Panth KM; Peeters SG; Claessens A; Schreurs WM; Nap M; Warmerdam FA; Erdkamp FL; Sosef MN; Lambin P
BMC Cancer; 2016 Aug; 16():644. PubMed ID: 27535748
[TBL] [Abstract][Full Text] [Related]
11. The value of post-neoadjuvant therapy PET-CT in the detection of interval metastases in esophageal carcinoma.
Blom RL; Schreurs WM; Belgers HJ; Oostenbrug LE; Vliegen RF; Sosef MN
Eur J Surg Oncol; 2011 Sep; 37(9):774-8. PubMed ID: 21726976
[TBL] [Abstract][Full Text] [Related]
12. Metachronous adenocarcinoma of the remnant oesophagus 15 years following multimodal therapy.
Croghan S; McCormack O; Muldoon C; Ravi N; Reynolds JV
Ir Med J; 2015 Jan; 108(1):22-3. PubMed ID: 25702351
[TBL] [Abstract][Full Text] [Related]
13. Detection of interval distant metastases: clinical utility of integrated CT-PET imaging in patients with esophageal carcinoma after neoadjuvant therapy.
Bruzzi JF; Swisher SG; Truong MT; Munden RF; Hofstetter WL; Macapinlac HA; Correa AM; Mawlawi O; Ajani JA; Komaki RR; Fukami N; Erasmus JJ
Cancer; 2007 Jan; 109(1):125-34. PubMed ID: 17146785
[TBL] [Abstract][Full Text] [Related]
14. [Therapeutic decisions in patients with operable, non-metastatic oesophageal cancer].
Fuchs HF; Hölscher AH
Zentralbl Chir; 2014 Feb; 139(1):32-6. PubMed ID: 24585195
[TBL] [Abstract][Full Text] [Related]
15. Metachronous pulmonary metastasis after radical esophagectomy for esophageal cancer: prognosis and outcome.
Takemura M; Sakurai K; Takii M; Yoshida K
J Cardiothorac Surg; 2012 Oct; 7():103. PubMed ID: 23031450
[TBL] [Abstract][Full Text] [Related]
16. Worldwide Oesophageal Cancer Collaboration guidelines for lymphadenectomy predict survival following neoadjuvant therapy.
Stiles BM; Nasar A; Mirza FA; Lee PC; Paul S; Port JL; Altorki NK
Eur J Cardiothorac Surg; 2012 Oct; 42(4):659-64. PubMed ID: 22491667
[TBL] [Abstract][Full Text] [Related]
17. Induction chemotherapy followed by surgery for advanced oesophageal cancer.
Toxopeus EL; Talman S; van der Gaast A; Spaander VM; van Rij CM; Krak NC; Biermann K; Tilanus HW; Mathijssen RH; van Lanschot JJ; Wijnhoven BP
Eur J Surg Oncol; 2015 Mar; 41(3):323-32. PubMed ID: 25534280
[TBL] [Abstract][Full Text] [Related]
18. New insights in the lymphatic spread of oesophageal cancer and its implications for the extent of surgical resection.
Cense HA; van Eijck CH; Tilanus HW
Best Pract Res Clin Gastroenterol; 2006; 20(5):893-906. PubMed ID: 16997168
[TBL] [Abstract][Full Text] [Related]
19. Esophagectomy Timing After Neoadjuvant Therapy for Distal Esophageal Adenocarcinoma.
Franko J; Voynov G; Goldman CD
Ann Thorac Surg; 2016 Mar; 101(3):1123-30. PubMed ID: 26652139
[TBL] [Abstract][Full Text] [Related]
20. Chest wall metastasis from oesophageal adenocarcinoma: a rare presentation.
Gogalniceanu P; Jarral OA; Purkayastha S; Aggarwal R; Zacharakis E
Updates Surg; 2011 Sep; 63(3):223-6. PubMed ID: 21442344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
